business

Aurobindo gets final nod from US FDA on generic drug

Aurobindo Pharma got final approval from the US Food & Drug Administration (US FDA) to manufacture and market generic drug, Piperacillin and Tazobactam injection of varying strength packed in single use vials, the company said in a press release Tuesday.

first published: May 24, 2011 12:33 pm